2014 molecular cpt coding with palmetto pti codes … · 2014 molecular cpt coding with palmetto...

2014 Molecular CPT Coding with Palmetto PTI codes

UPDATED 10/01/2014

The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the

Quest Diagnostics Test Name

Quest Diagnostics Order Code 2014 CPT Codes Palmetto PTI

19911A>G Mutation Analysis 16533(X) 81400 PBF19

19911A>G Mutation Analysis (NY) 16534(X) 81400 PBF19

ABL Kinase Domain Mutation in CML, Cell-based 16029(X) 81403 PBC33

ABL Kinase Domain Mutation in CML, Plasma-based, Leumeta(R) 16031(X) 81403 PBC33

ABL T315I Mutation in CML, Cell-based 19783(X) 81401 PBC34

ABL T315I Mutation in CML, Plasma-based, Leumeta(R) 19782(X) 81401 PBC34

AccuType(R) IL28B 90251(X) 81400 PB648

AccuType(R) IL28B (NY) 90252(X) 81400 PB648

AccuType(R) CP, Clopidogrel CYP2C19 Genotype 16924(X) 81225 PBE76

AccuType(R) CP, Clopidogrel CYP2C19 Genotype (NY) 16925(X) 81225 PBE76

AccuType(R) Warfarin 16160(X) 81355, 81227 PBE78

AccuType(R) Warfarin (NY) 16161(X) 81355, 81227 PBE78

Achondroplasia Mutation Analysis 16061(X) 81401 PBE79

Achondroplasia Mutation Analysis (NY) 16062(X) 81401 PBE79

payor being billed.

2014 Molecular CPT Coding with Palmetto PTI codes UPDATED 10/01/2014

The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT



Acute Myeloid Leukemia Prognostic Panel (normal karyotype) 90871(X)

81403, 81310, 81245, 81479

PBC59, PBC43, PBC93

Acute Myeloid Leukemia Prognostic Panel (normal karyotype) (NY) 91867(X)

81403, 81310, 81245, 81479

PBC59, PBC43, PBC93

Admark ApoE Genotype Analysis 10642(X) 81401 PB870

Alpha-1 Antitrypsin (AAT) Mutation Analysis 15340(X) 81332 PB633

Alpha-1 Antitrypsin (AAT) Mutation AnalysisN (NY) 15341(X) 81332 PB633

Alpha-1-Antitrypsin (AAT) Quantitation and Mutation Analysis 17307(X) 81332, 82103 PB634

Alpha-1-Antitrypsin (AAT) Quantitation and Mutation Analysis (NY) 17313(X) 81332, 82103 PB634

Alpha-Globin Common Mutation Analysis 11175(X) 81257 PB739

Alpha-Globin Common Mutation Analysis (NY) 11174(X) 81257 PB739

Alpha-Globin Common Mutation Analysis, Fetus 91711(X) 81257 PB739

Alpha-Globin Gene Sequencing 16116(X) 81405 PBF01

Alpha-Globin Gene Sequencing (NY) 16117(X) 81405 PBF01

Alpha-Globin Gene Deletion or Duplication 16124(X) 81404 PBE80

Alpha-Globin Gene Deletion or Duplication (NY) 16125(X) 81404 PBE80

AML1/ETO t(8;21) Quantitative Real-Time PCR 14995(X) 81401 PB946

coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payor being billed.

2





Amyloidosis Evaluation 14759(X) 81479 PBG03

Angiotensin Converting Enzyme (ACE) Polymorphism (Insertion/Deletion) 11210(X) 81400 PBF41

Angiotensin Converting Enzyme (ACE) Polymorphism (Insertion/Deletion) (NY) 11211(X) 81400 PBF41

Angiotensin II Type 1 Receptor (AGTR1) Gene 1166A>C Polymorphism 11118(X) 81400 PBF42

Angiotensin II Type 1 Receptor (AGTR1) Gene 1166A>C Polymorphism (NY) 11242(X) 81400 PBF42

APC Gene Deletion or Duplication 16930(X) 81203 PBF43

APC Gene Sequencing 16934(X) 81201 PBF44

Ashkenazi Jewish Panel (4 tests) 90994(X)

81220 (CF), 81255 (TAY SACHS), 81200 (CANAVAN), 81260 (FAMILIAL DYS) PBG42

Ashkenazi Jewish Panel (11 Tests) 90891(X)

81220 (CF), 81200 (CANAVAN), 81251 (GAUCHER), 81242 (FANCONI), 81209 (BLOOM), 81255 (TAY SACHS), 81260 (FAMILIAL DYS), 81330 (NEIMANN PICK), 81290 (MUCOLILPIDOSIS), 81250 (GLYCOGEN STORAGE), 81205 (MAPLE SYRUP) PBG41


3





Ashkenazi Jewish Panel (11 Tests) (NY) 90892(X)

81220 (CF), 81200 (CANAVAN), 81251 (GAUCHER), 81242 (FANCONI), 81209 (BLOOM), 81255 (TAY SACHS), 81260 (FAMILIAL DYS), 81330 (NEIMANN PICK), 81290 (MUCOLILPIDOSIS), 81250 (GLYCOGEN STORAGE), 81205 (MAPLE SYRUP) PBG41

B-Cell Gene Rearrangement, Qualitative PCR, Cell-based 14868(X) 81261 PBC36

B-Cell Gene Rearrangement, Qualitative PCR, Plasma-based, Leumeta(R) 16119(X) 81261 PBC36

B-cell Receptor IGH Gene Rearrangement, PCR (includes Pathologist interpretation) 90362(X)

81261, 84999 (HCPCS: G0452) PBZB9

B-cell Receptor IGK Gene Rearrangement, PCR (includes Pathologist interpretation) 90363(X)

81264, 84999 (HCPCS: G0452) PBZC1

B-cell Clonality Panel (IGH, IGK), PCR 91635(X)

81261, 81264, 84999 (HCPCS: G0452) PBZB9, PBZC1

BCR-ABL1 Gene Rearrangement, Quantitative PCR (includes BCRABL1/ ABL1 * P190 BCR-ABL1 * P210 BCR-ABL1) 91065(X)

81206 and/or 81207

PBAAB and/ or PBAAA

BCR-ABL1 Kinase Domain Mutation, 35-Nucleotide Insertion 16876(X) 81403 PBC61

Beta2-Adrenergic Receptor Mutations 16176(X) 81401 PBF80


4





Beta2-Adrenergic Receptor Mutations (NY) 16177(X) 81401 PBF80

Beta-fibrinogen -455G>A Mutation 16182(X) 81400 PBF18

Beta-fibrinogen -455G>A Mutation (NY) 16183(X) 81400 PBF18

Beta-Globin Complete 14974(X) 81404 PBE81

Beta-Globin Complete (NY) 14979(X) 81404 PBE81

Beta-Globin Complete, Fetus 91709(X) 81404 PBE81

Beta Globin Gene Dosage Analysis 16346(X) 81403 PBF17

Beta Globin Gene Dosage Analysis (NY) 16347(X) 81403 PBF17

Cardio IQ(R) KIF6 Genotype 90645(X) 81479 PBD23

Cardio IQ(R) LPA Aspirin Genotype 90553(X) 81479 PB855

Biotinidase Deficiency Mutation Analysis 16526(X) 81404 PBF20

Biotinidase Deficiency Mutation Analysis (NY) 16655(X) 81404 PBF20

Biotinidase Activity with Reflex to Mutation Analysis 16537(X)

82261 with reflex to 81404

PBF20 (for 81404)

Bloom Syndrome DNA Mutation Analysis 90872(X) 81209 PBE82

Bloom Syndrome DNA Mutation Analysis (NY) 90873(X) 81209 PBE82


5





BRCAvantage(TM), Ashkenazi Jewish Screen 91864(X) 81212 PBABB

BRCAvantage(TM), Comprehensive 91863(X) 81211, 81213 PBABA

BRCAvantage(TM), Rearrangements 91866(X) 81213, 81479 PBABE

BRCAvantage(TM), Single Site 91865(X) 81215 or 81217 PBZBC or PBABD

BRAF Mutation Analysis 16767(X) 81210 PBC87

Melanoma, BRAF V600E, V600K 92131(X) 81210 ZB064

BRAF Mutation Analysis Papillary Thyroid Cancer 90477(X) 81210 PBC88

BRAF Mutation Analysis, ASO 90868(X) 81210 PBC86

C Kit Mutations w/ Reflex to PDGFRA Mutations 16237(X)


PBC37 with reflex to PBC95

CAH (21-Hydroxylase Deficiency) Common Mutations 14755(X) 81402 PBE83

CAH (21-Hydroxylase Deficiency) Common Mutations (NY) 15063(X) 81402 PBE83

CAH (21-Hydroxylase Deficiency) Common Mutations, Fetal Cells 91680(X) 81402 PBE83

CAH (21-Hydroxylase Deficiency) Rare Mutations 16072(X) 81405 PBF22

CAH (21-Hydroxylase Deficiency) Rare Mutations (NY) 16073(X) 81405 PBF22

Calreticulin (CALR) Mutation Analysis 92074(X) 81479 PBACZ


6





Canavan Disease Mutation Analysis 90905(X) 81200 PBE84

Canavan Disease Mutation Analysis (NY) 90906(X) 81200 PBE84

Cardio IQ(TM) 9p21 Genotype 90648(X) 81479 PB856

Cardio IQ(TM) ApoE Genotype 90649(X) 81401 PBD28

Cardio IQ(TM) KIF6 Genotype 90645(X) 81479 PBD23

Cardio IQ(TM) LPA Aspirin Genotype 90553(X) 81479 PB855

Cardio IQ(TM) LPA Intron-25 Genotype 90655(X) 81479 PBD26

Cardio IQ(TM) 4q25-AF Risk Genotype 90948(X) 81479 PBD25

Cardio IQ(TM) CYP2C19 Genotype 90668(X) 81225 PBD27

CBFB/MYH11 inv(16), Quantitative Real-Time PCR 14992(X) 81401 PBF23

CEBPA Mutation Analysis 90812(X) 81403 PBC59

CEBPA Mutation Analysis, Extracted DNA 90813(X) 81403 PBC60

CFTR Intron 8 Poly-T Analysis 15053(X) 81224 PBR20

CFTR Intron 8 Poly-T Analysis (NY) 14700(X) 81224 PBR20

Chromosomal Microarray, Oncology, ClariSure(R) Oligo-SNP, FFPE 91426(X) 81406 PBZB1


7





Melanoma, Chromosomal Microarray, ClariSure(R) Oligo-SNP 91427(X) 81406 PBZB2

Chromosomal Microarray, Hematologic Malignancy, ClariSure(R) Oligo-SNP 90961(X) 81406 PBF45

Chronic Lymphocytic Leukemia, IgVH Mutation Status, Cell-based 15480(X) 81263 PBC38

Chronic Lymphocytic Leukemia, IgVH Mutation Status, Leumeta® 17702(X) 81263 PBC38

C-KIT Mutation Analysis, Cell-based 19961(X) 81404 PBC37

c-kit Mutation Analysis, Plasma-based, Leumeta(R) 19960(X) 81404 PBC37

CKR-5 Gene, DNA Mutation Analysis 38956(X) 81400 PBF25

Colorectal Cancer Mutation Panel (KRAS, PIK3CA, BRAF, NRAS) 18902(X)

81275, 81210, 81404, 81404

PBF73, ZBC57, PBC87, PBC55,

ColoVantage™ (methylated Septin 9) 16983(X) 81401 PBE85

ColoVantage™ (methylated Septin 9) (NY) 16984(X) 81401 PBE85

Complete Cadasil Evaluation 10978(X) 81406 PB866

Complete HNPP Evaluation 15590(X) 81324, 81325 PBG48

CYP2C19 Genotyping 16605(X) 81225 ZB763

CYP2C19 Genotyping (NY) 16608(X) 81225 ZB763

Cystic Fibrosis Complete Rare Mutation Analysis, Entire Gene Sequence 10917(X) 81223 PBF66


8





Cystic Fibrosis Complete Rare Mutation Analysis, Entire Gene Sequence (NY) 10919(X) 81223 PBF66

Cystic Fibrosis D1152H Mutation Analysis 15335(X) 81221 PBF67

Cystic Fibrosis D1152H Mutation Analysis (NY)

15336(E 4X) 81221 PBF67

Cystic Fibrosis DNA Analysis, Fetus 10226(X) 81220, 88235 PBF68

Cystic Fibrosis DNA Analysis, Fetus (NY) 10478(X) 81220, 88235 PBF68

Cystic Fibrosis Gene Deletion or Duplication 16080(X) 81222 PBE86

Cystic Fibrosis Gene Deletion or Duplication (NY) 16081(X) 81222 PBE86

Cystic Fibrosis Rare Mutation Analysis, One Exon 10913(X) 81221 PBE87

Cystic Fibrosis Rare Mutation Analysis, One Exon (NY) 10914(X) 81221 PBE87

Cystic Fibrosis Rare Mutation Analysis, Two Exon 10915(X) 81221 PBE88

Cystic Fibrosis Rare Mutation Analysis, Two Exon (NY) 10916(X) 81221 PBE88

Cystic Fibrosis Screen 10458(X) 81220 ZB749

Cystic Fibrosis Screen (NY) 10463(X) 81220 ZB749

Cystic Fibrosis Mutation Screen with reflex to CF Complete 17726(X)


ZB749 with reflex to PBF66

Cystic Fibrosis Mutation Screen with reflex to CF Complete (NY) 17727(X)


ZB749 with reflex to PBF66


9





Cytochrome P450 2C9 Genotype 11294(X) 81227 PBF64

Cytochrome P450 2C9 Genotype (NY) 11295(X) 81227 PBF64

Cytochrome P450 2D6 Genotype 10490(X) 81226 PBE89

Cytochrome P450 2D6 Genotype (NY) 14589(X) 81226 PBE89

Cytochrome P450 2D6/2C19 Genotyping 17634(X) 81225, 81226 PBE76, PBE89

Cytochrome P450 2D6/2C19 Genotyping (NY) 17662(X) 81225, 81226 PBE76, PBE89

Cytomegalovirus Genotype 14980(X) 87910 PBD29

Dihydropyrimidine Dehydrogenase (DPD) Gene Mutation Analysis 15538(X) 81400 PBF48

Dihydropyrimidine Dehydrogenase (DPD) Gene Mutation Analysis (NY) 15539(X) 81400 PBF48

Dystonia (DYT1) DNA Test 14678(X) 81400 PBG11

EML4-ALK Gene Fusion, PCR 16344(X) 81401 PBC54

Epidermal Growth Factor Receptor (EGFR) Mutation Analysis 16460(X) 81235 PBC98

Factor V (Leiden) Mutation Analysis 17900(X) 81241 PBF85

Factor V (Leiden) Mutation Analysis (NY) 17901(X) 81241 PBF85

Factor V (Leiden) Mutation Analysis w/Reflex to HR2 Mutation 17904(X)


PBF85 with reflex to PBE90


10





Factor V HR2 Allele DNA Mutation Analysis 17902(X) 81400 PBE90

Factor V HR2 Allele DNA Mutation Analysis (NY) 17903(X) 81400 PBE90

Factor VII R353Q Muation Analysis 16180(X) 81400 PBF26

Factor VII R353Q Muation Analysis (NY) 16181(X) 81400 PBF26

Factor XI Mutation Analysis (Ashkenazi Jewish) 16023(X) 81401 PBF27

Factor XI Mutation Analysis (Ashkenazi Jewish) (NY) 16024(X) 81401 PBF27

Factor XIII V34L Mutation Analysis 16178(X) 81400 PBF28

Factor XIII V34L Mutation Analysis (NY) 16179(X) 81400 PBF28

Familial Adenomatous Polyposis (FAP) Screen 10623(X) 81201, 81203 PBG45

Familial Dysautonomia Mutation Analysis 90912(X) 81260 PBE94

Familial Dysautonomia Mutation Analysis (NY) 90913(X) 81260 PBE94

Familial Mediterranean Fever Mutation Analysis 16141(X) 81402 PBF03

Familial Mediterranean Fever Mutation Analysis (NY) 16142(X) 81402 PBF03

Fanconi Anemia DNA Mutation Analysis (NY) 90898(X) 81242 PBG43

Fanconi Anemia DNA Mutation Analysis 90897(X) 81242 PBG43


11





FLT3 (ITD) and TKD Variant Detection by PCR 90574(X) 81245, 81479 PBC93

Follicular Lymphoma, bcl-2/JH t(14;18), Real-time PCR, Cell-based 15007(X) 81402 PBC39

Follicular Lymphoma, bcl-2/JH t(14;18), Real-time PCR, Leumeta(R) 17690(X) 81402 PBC39

Fragile X DNA Analysis, Fetus 16300(X) 81243 PBF70

Fragile X DNA Analysis, Fetus (NY) 16301(X) 81243 PBF70

FSHD DNA Deletion Test 17029(X) 81404 PBG47

Galactosemia Mutation Analysis 16613(X) 81401 PBF82

Galactosemia Mutation Analysis (NY) 16614(X) 81401 PBF82

Gaucher Disease, DNA Mutation Analysis 90907(X) 81251 PBE92

Gaucher Disease, DNA Mutation Analysis (NY) 90908(X) 81251 PBE92

Genomic Alterations, Oncology, ClariSure(R) CGH 16800(X) 81406 PBF45

Chromosomal Microarray, POC, ClariSure(R) Oligo-SNP 90929(X) 81229 PBABR

Genomic Alterations, Postnatal, ClariSure(R) Oligo-SNP Array 16478(X) 81229 PB635

Chromosomal Microarray, Prenatal, ClariSure(R) Oligo-SNP 90927(X) 81229 PBABR

Glycogen Storage Disease Type Ia Mutation Analysis (Ashkenazi Jewish) 90915(X) 81250 PBK85


12





Glycogen Storage Disease Type Ia Mutation Analysis (Ashkenazi Jewish), NY 90916(X) 81250 PBK85

Hemophilia A (Factor VIII) Inversions 90828(X) 81403 PBZB3

Hepatitis B Virus DNA, Quantitative, Real-Time PCR 8369(X) No 2012 tier code ZB814

Hepatitis B Virus Drug Resistance, Genotype, and BCP/Precore Mutations 10529(X) 87912 PB738

Hereditary Hemochromatosis DNA Mutation Analysis 35079(X) 81256 PBF71

Hereditary Hemochromatosis DNA Mutation Analysis (NY) 36193(X) 81256 PBF71

Hereditary Pancreatitis Mutation Screen 15383(X) 81401 ZBG01

HEXA Mutation Analysis, Gene Sequencing 16612(X) 81406 PBF30

Influenza A H1N1 (2009) Oseltamivir (H274Y) Resistance Detection 16962(X) 87999 ZB672

HLA-B27, DNA Typing 15584(X) 81374 PBG25

HLA-A,B Class I DNA Typing 15757(X) 81373 (x2) PBA77

HLA Class I A,B,C DNA Typing 15484(X) 81372 PBA71

HLA Class II DR, DQ DNA Typing (15485) 15485(X) 81375 PBA74

HLA DQ Class II DNA Typing 10953(X) 81376 PBG27

HLA Typing for Celiac Disease 17135(X) 81382, 81376 PBA73


13





HLA-A Class I DNA Typing 10951(X) 81373 PBA68

HLA-A High Resolution SBT Typing 17397(X) 81380 PBG15

HLA A Low Resolution Qual HLA A2N 92077(X) 81373

HLA HR, ABC DR DQ Qual 92076(X) 81382 (x2), 81379

HLA ABC High Resolution Qual HLAHR, ABC 92078(X) 81379

HLA-A,B, Intermediate Resolution Typing for Transplantation 92158(X) 81373 (x2)

HLA-A,B,C, Intermediate Resolution Typing for Transplantation 92157(X) 81372

HLA-DRB1, DQB1, Intermediate Resolution Typing for Transplantation 92159(X) 81376 (x2)

HLA-DRB1, Intermediate Resolution Typing for Transplantation 92160(X) 81376

HLA-DRB3, 4, 5, Intermediate Resolution Typing for Transplantation 92161(X) 81376

HLA-A,B Class I DNA Typing (15757) 15757(X) 81373 (x2) PBA77

HLA-A,B,C CLASS I DNA TYPING 15484(X) 81372 PBA71

HLA-A2 High Resolution SBT Subtyping 17492(X) 81381 PBK78

HLA-A2 Subtyping 92044(X) 81380 PBA68

HLA-A29 DNA Typing 16773(X) 81374 PBG17


14





HLA-B Class I DNA Typing 10950(X) 81373 PBA69

HLA-B High Resolution SBT Typing 17396(X) 81380 PBG18

HLA-B*1502 Typing 40045(X) 81381 PBG23

HLA-B*5701 Typing 19774(X) 81381 PBG24

HLA-B27, DNA Typing 15584(X) 81374 PBG25

HLA-B51 DNA Typing 16775(X) 81374 PBG26

HLA-C Class I DNA Typing 15463(X) 81373 PBA70

HLA-C High Resolution SBT Typing 17395(X) 81380 PBG19

HLA-DRB1 Class II DNA Typing 10952(X) 81376 PBA72

HLA-DQA1 DNA Typing 19525(X) 81376 PBG28

HLA-DQB1 Class II DNA Typing 10953(X) 81376 PBG27

HLA-DQB1 High Resolution SBT Typing 17394(X) 81382 PBG20

HLA Class II DR, DQ DNA Typing 15485(X) 81375 PBA74

HLA-DRB 3*4*5 DNA Typing 19526(X) 81376 PBA75

HLA-DRB1 High Resolution SBT Typing 17393(X) 81382 PBG21

Human Platelet Antigen 1 Genotype 10707(X) 81400 PBE93

Huntington Disease Mutation Analysis 10247(X) 81401 PBE95

Huntington Disease Mutation Analysis (NY) 14871(X) 81401 PBE95 JAK2 Exons 12 and 13 Mutations, Qualitative, Leumeta(R) 16536(X) 81403 PBC40 JAK2 Mutation (V617F) Analysis, Quantitative, Plasma-based, Leumeta(R) 16175(X) 81270 PB646 JAK2 V617F, Qualitative, Leumeta® with Reflex to Exons 12,13 16539(X)

81270 reflex to 81403

PBF78 with reflex to PBC40


15





JAK2 V617F, Qualitative, Leumeta® with Reflex to Exons 12,13 and Reflex to MPL W515, S505 16538(X)

81270 reflex to 81403 (JAK 12,13) and/or reflex 81402

PBF78 with reflex to PBC40 and/or reflex PBC42

JAK2 Mutation (V617F), Quantitative 18950(X) 81270 PBF77

Stratify JCV ™ Antibody w/reflex to Inhibition Assay 90257(X)

86711 w/reflex to 86711

KIT D816, Mutation analysis (Mastocytosis) 91772(X) 81402 PBABQ

KRAS Mutation Analysis 16510(X) 81275 PBF73 Long Chain Acyl-CoA Dehydrogenase (LCHAD) Mutation Analysis (NY) 11247(X) 81479 PBF31 Long Chain Acyl-CoA Dehydrogenase (LCHAD) Mutation Analysis 11244(X) 81479 PBF31

Lung Cancer Mutation Panel (EGFR, KRAS, ALK) 91216(X)

81235, 81275, 88271 (x2), 88274 PBC98, PBF73

Lymphocyte Clonality Panel, PCR 91634(X)

81261, 81264, 81342, 81340, 84999 (HCPCS: G0452)

PBZB7, PBZB8, PBZB9, PBZC1

Lynch Syndrome, MLH1 Sequencing and Deletion/Duplication 91460(X) 81292, 81294 PBZA3

Lynch Syndrome, MLH1 Familial Deletion/Duplication 91584(X) 81294 PBZA9 Lynch Syndrome, MSH2 Sequencing and Deletion/Duplication (Including EPCAM) 91471(X)

81295, 81297, 81403 PBZA4

Lynch Syndrome, MSH6 Sequencing and Deletion/Duplication 91458(X) 81298, 81300 PBZA5 Lynch Syndrome, PMS2 Sequencing and Deletion/Duplication 91457(X) 81317, 81319 PBZA6

Lynch Syndrome, PMS2 Familial Deletion/Duplication 91463(X) 81319 PBZA7 Lynch Syndrome, MSH2 Familial Deletion/Duplication (Including EPCAM) 91459(X) 81297, 81403 PBZA8


16





Lynch Syndrome Panel 91461(X)

81292, 81295, 81298, 81317, 81294, 81300, 81319, 81403, 81297 PBZA2

Macular Degeneration Mutation Analysis 16155(X) 81401 PBF32

Macular Degeneration Mutation Analysis(NY) 16156(X) 81401 PBF32 Mantle Cell Lymphoma, bcl-1/JH t(11;14), Real-time PCR, Cell-based 14991(X) 81401 PBC41 Mantle Cell Lymphoma, bcl-1/JH t(11;14), Real-time PCR, Leumeta(R) 17679(X) 81401 PBC41 Maple Syrup Disease (MSUD) Mutation Analysis (Ashkenazi Jewish) 90909(X) 81205 PBE96 Maple Syrup Disease (MSUD) Mutation Analysis (Ashkenazi Jewish) (NY) 90911(X) 81205 PBE96

Maternal Cell Contamination Study, STR Analysis 10262(X) 81265 PBE97

Maternal Cell Contamination Study, STR Analysis (NY) 10477(X) 81265 PBE97 Medium Chain Acyl-CoA Dehydrogenase (MCAD) Mutation Analysis 11176(X) 81400 PBF34 Medium Chain Acyl-CoA Dehydrogenase (MCAD) Mutation Analysis (NY) 10921(X) 81400 PBF34 Medium Chain Acyl-CoA Dehydrogenase (MCAD) Gene Sequencing 91284(X) 81401 PBZB4

Melanoma, BRAF V600 Mutation, Cobas 90956(X) 81210 ZB794

MEN2 and FMTC Mutations, Exons 10, 11, 13-16 36587(X) 81404, 81405 PBF98

MEN2 and FMTC Mutations, Exons 10, 11, 13-16 (NY) 36091(X) 81404, 81405 PBF98 Methylenetetrahydrofolate Reductase (MTHFR), DNA Mutation Analysis 17911(X) 81291 PBF93 Methylenetetrahydrofolate Reductase, DNA Mutation Analysis (NY) 17912(X) 81291 PBF93

Microsatellite Instability (MSI), HNPCC 14989(X) 81301 PBC94


17





Mitochondrial DNA Disorders, Panel I 10631(X) 81479 PB737

Mitochondrial DNA Disorders, Panel II 10632(X) 81479 PBG34

MLH1 Mutation, One Exon, HNPCC 14984(X) 81293 PBF53

MLH1 Mutation, One Exon, HNPCC (NY) 15012(X) 81293 PBF53 MPL W515 and MPL S505 Mutation Analysis, Qualitative, Leumeta(R) 16184(X) 81402 PBC42

MSH2 Gene Sequencing, HNPCC 16929(X) 81295 PBF54

MSH2 Mutation, One Exon, HNPCC 14981(X) 81296 PBF55

MSH2 Mutation, One Exon, HNPCC (NY) 15013(X) 81296 PBF55

MSH6 Mutation, HNPCC (NY) 15015(X) 81298 PBF56

MSH6 Gene Deletion or Duplication 91230(X) 81300 PBZ52

MSH6 Mutation, One Exon, HNPCC 14983(X) 81299 PBF57

MSH6 Mutation, One Exon, HNPCC (NY) 15014(X) 81299 PBF57

Mucolipidosis Type IV Mutation Analysis 90899(X) 81290 PBF35

Mucolipidosis Type IV Mutation Analysis (NY) 90901(X) 81290 PBF35

MYD88, Mutation Analysis 91771(X) 81479 PBABP

Myelodysplastic Syndrome (MDS) Mutations, Sequencing 91396(X)

81404, 81275, 81403 (x2), 81479 PBAAC

Myelodysproliferative Neoplasm Mutation (w/o BCR/ABL, JAK2, MPL) 91401(X)

81404, 81275, 81403 (x2), 81479 PBAAC

Myotonic Dystrophy DNA Test 36164(X) 81401 PBG39

Niemann-Pick Disease Mutation Analysis 90893(X) 81330 PBF36

Niemann-Pick Disease Mutation Analysis (NY) 90895(X) 81330 PBF36

NPM (Exon 12) Mutation Analysis, Cell-based 16158(X) 81310 PBC43


18





NPM (Exon 12) Mutation Analysis, Plasma-based, Leumeta(R) 16159(X) 81310 PBC43

NRAS Mutation Analysis 16818(X) 81404 PBC55

OncoVantage™ 91919(X)

81210, 81235, 81275, 81321, 81403 (x5), 81404 (x6), 81405 (x2), 81479 PBBBM

P53 Mutation Analysis, Plasma-based, Leumeta(R) 16515(X) 81405 PBC44

Pain Management, CYP450 3A4 Genotype, Qual 91617(X) 81401 PBZB5

Pain Management, CYP450 3A5 Genotype, Qual 91618(X) 81479 PBZB6

Pain Management, CYP450 2D6/2C19 Genotype, Qual 18946(X) 81226, 81225 PBE76, PBE89

PAX8/PPAR translocation 90474(X) 81401 PBC56

PDGFRA Mutation Analysis 16859(X) 81404 PBC95

Phenylketonuria (PKU) Mutation Analysis 16152(X) 81406 PBF37

Phenylketonuria (PKU) Mutation Analysis (NY) 16153(X) 81406 PBF37

PIK3CA Mutation Analysis 16897(X) 81404 ZBC57

Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G 11368(X) 81400 PB643

Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G (NY) 14518(X) 81400 PB643 PML/RARA t(15;17), Quantitative Real-Time PCR, Cell-based 14994(X) 81315 ZBC58 PML/RARA t(15;17), Quantitative Real-Time PCR, Plasma-based, Leumeta(R) 70182(X) 81315 ZBC58

PMP22 Duplication/Deletion DNA Test 824(X) 81324 PBG49 Prader-Willi/Angelman Syndrome, DNA Methylation Analysis 11369(X) 81331 PB740 Prader-Willi/Angelman Syndrome, DNA Methylation Analysis (NY) 14470(X) 81331 PB740


19





Prenatal Carrier Screen (CF, Fragile X, SMA) 90949(X)

81220, 81243, 81401 with possible southern blot

ZB749, PB320, PBBZ0

Prostate Cancer Antigen 3 (PCA3) 91054(X) 81479 ZBA41

Progensa(R) PCA3 92028(X) 81479 ZBA41

Prothrombin (Factor II) 20210G>A Mutation Analysis 17909(X) 81240 PBF84 Prothrombin (Factor II) 20210G>A, Mutation Analysis (NY) 17910(X) 81240 PBF84

RAS Mutation Analysis, Cell-based 16128(X)

81403, 81404, 81275 PBD78

RAS Mutation Analysis, Plasma-based Leumeta(R) 16127(X)

81403, 81404, 81275 PBD78

RAS Mutation Analysis, Thyroid Cancer 90479(X)

81403, 81404, 81275 PBD79

Renal Transplant Monitoring (FOXP3, Granzyme B, Perforin, IP10) 90986(X) 81479 PBZ51 Renal Transplant Monitoring (FOXP3, Granzyme B, Perforin, IP10) (NY) 90987(X) 81479 PBZ51

Resistance to Thyroid Hormone (RTH) Mutation Analysis 16053(X) 81405 PBF38

Resistance to Thyroid Hormone (RTH) Mutation Analysis (NY) 16054(X) 81405 PBF38

RET/PTC Rearrangement, Thyroid Cancer 90473(X) 81479 PBC97

Rett Syndrome Mutation Analysis 15088(X) 81302 PBF99

Rett Syndrome Mutation Analysis (NY) 15089(X) 81302 PBF99

Rett Syndrome Rearrangement (Deletion or Duplication) 16662(X) 81304 PB642

Sarcoma Mutation Analysis Panel, Pediatric, PCR 19884(X)

81401 (x5), 81479 PBD75

SHOX (GHD) DNA Sequencing and Deletion 91566(X) 81405, 81479 PBO50

Sickle Cell Anemia, DNA Probe Analysis, Fetus 26382(X) 88235, 81401 PBF74

Sickle Cell Anemia, DNA Probe Analysis, Fetus (NY) 36194(X) 88235, 81401 PBF74


20





SMA Carrier Screen 18041(X) 81401 PBBZ0

SMA Diagnostic Test 16869(X) 81401 PBBZ0

Small Fiber Painful Axonal Profile 10539(X)

83516, 83520 (x2), 81404 PBJ20

Tamoxifen P450 Genotype 16731(X) 81226 PBE06

Tamoxifen P450 Genotype (NY) 16732(X) 81226 PBE06

Tay Sachs Disease Mutation Analysis (NY) 90904(X) 81255 PBF62

Tay-Sachs Disease Mutation Analysis 90903(X) 81255 PBF62

T-cell Receptor (TCR) Beta Gene Rearrangement, PCR 91446(X)

81340, 84999 (HCPCS: G0452) PBZB8

T-cell Receptor (TCR) Gamma Gene Rearrangement, PCR 90509(X)

81342, 84999 (HCPCS: G0452) PBZB7

T-cell Clonality Panel (TCRB, TCRG), PCR 91445(X)

81342, 81340, 84999 (HCPCS: G0452) PBZB7, PBZB8

Thrombophilia DNA Mutation Analysis 17907(X) 81240, 81241 PBF91

Thrombophilia DNA Mutation Analysis (NY) 17908(X) 81240, 81241 PBF91 Thrombophilia Mutation Analysis with Reflex to HR2 Mutation 11126(X)

81240, 81241 with reflex to 81400

PBF85, PBF84 with reflex to PBE90

Thyroid Cancer Mutation Panel – BRAF, RAS, RET/PTC, PAX8/PPAR 90469(X)

81210, 81403, 81275, 81404 (x2), 81401

PBC88, PBD79, PBC97, PBC56

TPMT Genotype 37742(X) 81401 PBF58

TPMT Genotype (NY) 16108(X) 81401 PBF58

Trofile Co-receptor Tropism Assay 19995(X) 87906 PBC62

Twin Zygosity (NY) 10557(X) 81265 PBF39

Twin Zygosity 10556(X) 81265 PBF39

UGT1A1 Gene Polymorphism (TA Repeat) 17813(X) 81350 PBF61

UGT1A1 Gene Polymorphism (TA Repeat) (NY) 16111(X) 81350 PBF61


21





UGTIA1 Genotyping (NY) 16522(X) 81350 ZBB13

UGTIA1 Genotyping 16521(X) 81350 ZBB13

VEGF Polymorphism Analysis 16959(X) 81479 PBQ78

von Willebrand Disease Mutation Analysis 19837(X) 81406 PBF94

von Willebrand Disease Mutation Analysis (NY) 19838(X) 81406 PBF94

Wilms' Tumor 1 (WT1) Mutation Analysis 16896(X) 81405 PBF40

Wilson Disease Mutation Screen, ATP7B DNA Sequence 59142(X) 81406 PBG46

XSense(R), Fragile X with Reflex 16313(X)


PB320 with reflex to PBZA1

XSense(R), Fragile X with Reflex (NY) 16321(X)


PB320 with reflex to PBZA1

Y Chromosome Microdeletion, DNA Analysis 14679(X) 81403

Y Chromosome Microdeletion, DNA Analysis (NY) 16018(X) 81403


22


The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payor being billed.

23



Benzene Incident Urine (OSHA) 16883(X) 81099, 84600 PBQ33

Interferon-beta 1a (IFNB-1a) Ab 16201(X) 86382, 87253 PBK65

Interferon-beta 1b (IFNB-1b) Ab 16202(X) 86382, 87253 PB937

Interferon-beta IgG, MAID 19509(X) 83520 PB939

Limulus Amebocyte Lysate Assay 14453(X) 87999 PB966

Osmolality, Feces 968(X) 84999 PBK99

OVA1(TM) 16991(X) 84999 PB627

OVA1(TM) (includes FSH and LH) 16992(X)

84999, 83001, 83002 PBL00

2014 molecular cpt coding with palmetto pti codes … · 2014 molecular cpt coding with palmetto...

Documents